APRISO
NDC 65649-103, mesalamine, capsule, extended release, from Salix Pharmaceuticals, Inc..
- Product NDC
- 65649-103
- Status
- Listed
- Labeler
- Salix Pharmaceuticals, Inc.
- Dosage form
- CAPSULE, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA022301
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/65649-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- MESALAMINE375 mg/1
Pharmacologic classes
Aminosalicylate [EPC]; Aminosalicylic Acids [CS]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 65649-103-01 | 65649010301 | 1 BOTTLE in 1 CARTON (65649-103-01) / 4 CAPSULE, EXTENDED RELEASE in 1 BOTTLE |
| 65649-103-02 | 65649010302 | 1 BOTTLE in 1 CARTON (65649-103-02) / 120 CAPSULE, EXTENDED RELEASE in 1 BOTTLE |
Linked data
RxNorm, label and prices
Related lookups
FDA label sections
GET /v1/drugs/labels/7951139c-b271-45a4-b523-34b23800917b
Use it
Look up 65649-103 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/65649-103 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 65649-103. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.